Insider Buy/Sell Ratio for March 2026
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Healthcare
Buys230
Sells2123
Buy $$338.79M
Sell $$11.57B
Ratio1:34.16
% Change vs. Prior
Ratio -84.2%Value +496.4%
Technology
Buys139
Sells2709
Buy $$2.33B
Sell $$3.92B
Ratio1:1.68
% Change vs. Prior
Ratio +1333.3%Value +91.7%
Utilities
Buys17
Sells94
Buy $$973.35K
Sell $$5.38B
Ratio1:5531.88
% Change vs. Prior
Ratio -66.7%Value +275.1%
Energy
Buys100
Sells614
Buy $$26.35M
Sell $$4.26B
Ratio1:161.78
% Change vs. Prior
Ratio -65.4%Value +286.7%
Consumer Defensive
Buys56
Sells302
Buy $$17.21M
Sell $$1.06B
Ratio1:61.48
% Change vs. Prior
Ratio -28.6%Value +63.6%
Industrials
Buys203
Sells861
Buy $$43.98M
Sell $$988.40M
Ratio1:22.47
% Change vs. Prior
Ratio +189.3%Value -74.0%
Financial Services
Buys761
Sells801
Buy $$119.12M
Sell $$818.31M
Ratio1:6.87
% Change vs. Prior
Ratio -14.9%Value -72.5%
Consumer Cyclical
Buys120
Sells613
Buy $$274.92M
Sell $$471.02M
Ratio1:1.71
% Change vs. Prior
Ratio +375.2%Value -53.1%
Basic Materials
Buys68
Sells142
Buy $$56.92M
Sell $$558.41M
Ratio1:9.81
% Change vs. Prior
Ratio -29.7%Value +140.8%
Communication Services
Buys132
Sells296
Buy $$35.49M
Sell $$505.80M
Ratio1:14.25
% Change vs. Prior
Ratio -8.7%Value +67.5%
Real Estate
Buys86
Sells218
Buy $$21.92M
Sell $$114.19M
Ratio1:5.21
% Change vs. Prior
Ratio +106.8%Value -19.6%
By Industry
Medical - Instruments & Supplies
Buys25
Sells57
Buy $$14.98M
Sell $$7.62B
Ratio1:508.28
Independent Power Producers
Buys0
Sells11
Buy $$0.00
Sell $$5.30B
RatioAll Sells
Oil & Gas Exploration & Production
Buys57
Sells173
Buy $$10.23M
Sell $$3.06B
Ratio1:299.62
% Change vs. Prior
Ratio -11.7%Value +709.7%
Hardware, Equipment & Parts
Buys17
Sells304
Buy $$2.01B
Sell $$197.79M
Ratio10.14:1
% Change vs. Prior
Ratio +183024.5%Value +454.0%
Medical - Healthcare Information Services
Buys11
Sells90
Buy $$26.79M
Sell $$1.66B
Ratio1:61.82
Software - Application
Buys49
Sells794
Buy $$276.27M
Sell $$882.25M
Ratio1:3.19
Specialty Retail
Buys29
Sells223
Buy $$140.00M
Sell $$1.01B
Ratio1:7.20
% Change vs. Prior
Ratio +121.6%Value +80.2%
Biotechnology
Buys112
Sells1399
Buy $$136.85M
Sell $$834.27M
Ratio1:6.10
% Change vs. Prior
Ratio -67.9%Value +12.2%
Software - Infrastructure
Buys34
Sells543
Buy $$22.72M
Sell $$854.41M
Ratio1:37.60
% Change vs. Prior
Ratio -34.2%Value +88.6%
Computer Hardware
Buys2
Sells368
Buy $$351.04K
Sell $$793.91M
Ratio1:2261.61
Semiconductors
Buys9
Sells427
Buy $$1.52M
Sell $$744.87M
Ratio1:490.70
% Change vs. Prior
Ratio +1864.9%Value -55.5%
Medical - Diagnostics & Research
Buys14
Sells180
Buy $$9.77M
Sell $$699.40M
Ratio1:71.56
Oil & Gas Refining & Marketing
Buys1
Sells90
Buy $$30.31K
Sell $$440.96M
Ratio1:14548.31
Medical - Distribution
Buys0
Sells18
Buy $$0.00
Sell $$426.55M
RatioAll Sells
Aerospace & Defense
Buys14
Sells309
Buy $$13.82M
Sell $$367.11M
Ratio1:26.57
% Change vs. Prior
Ratio +5677.1%Value -85.9%
Transactions (8783)
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew โ CLO & Secretary
Shares
612
Price
$207.01
Total Value
$126.69K
Shares Held After
39,457
% of Holdings
1.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew โ CLO & Secretary
Shares
340
Price
$206.37
Total Value
$70.16K
Shares Held After
40,069
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew โ CLO & Secretary
Shares
460
Price
$205.18
Total Value
$94.38K
Shares Held After
40,409
% of Holdings
1.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew โ CLO & Secretary
Shares
200
Price
$204.17
Total Value
$40.83K
Shares Held After
40,869
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew โ CLO & Secretary
Shares
300
Price
$201.70
Total Value
$60.51K
Shares Held After
41,069
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew โ CLO & Secretary
Shares
93
Price
$200.62
Total Value
$18.66K
Shares Held After
41,369
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew โ CLO & Secretary
Shares
207
Price
$199.96
Total Value
$41.39K
Shares Held After
41,462
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew โ CLO & Secretary
Shares
100
Price
$199.00
Total Value
$19.90K
Shares Held After
41,669
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew โ CLO & Secretary
Shares
100
Price
$197.70
Total Value
$19.77K
Shares Held After
41,769
% of Holdings
0.2%
BLACKBAUD INC (BLKB)
Gregoire Kevin P. โ EVP, Chief Operating Officer
Shares
2,000
Price
$50.02
Total Value
$100.04K
Shares Held After
135,194
% of Holdings
1.5%
Kinetik Holdings Inc. (KNTK)
Wall Matthew โ EVP, Chief Operating Officer
Shares
3,222
Price
$46.92
Total Value
$151.18K
Shares Held After
585,556
% of Holdings
0.5%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
920
Price
$266.56
Total Value
$245.23K
Shares Held After
1,475,253
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
2,439
Price
$265.59
Total Value
$647.77K
Shares Held After
1,476,173
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
8,798
Price
$264.85
Total Value
$2.33M
Shares Held After
1,478,612
% of Holdings
0.6%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
2,043
Price
$263.70
Total Value
$538.74K
Shares Held After
1,487,410
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
2,380
Price
$262.44
Total Value
$624.62K
Shares Held After
1,489,453
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
2,962
Price
$261.41
Total Value
$774.29K
Shares Held After
1,491,833
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
3,128
Price
$260.49
Total Value
$814.80K
Shares Held After
1,494,795
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
1,377
Price
$259.87
Total Value
$357.84K
Shares Held After
1,497,923
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
470
Price
$258.38
Total Value
$121.44K
Shares Held After
1,499,300
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S โ Director
Shares
483
Price
$257.31
Total Value
$124.28K
Shares Held After
1,499,770
% of Holdings
0.0%
AleAnna, Inc. (ANNA)
WILDER C JOHN โ 10% Owner
Shares
34,595
Price
$3.34
Total Value
$115.55K
Shares Held After
30,297,356
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
1,700
Price
$266.42
Total Value
$452.92K
Shares Held After
1,403,155
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
6,000
Price
$265.16
Total Value
$1.59M
Shares Held After
1,404,855
% of Holdings
0.4%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
4,852
Price
$264.64
Total Value
$1.28M
Shares Held After
1,410,855
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
2,248
Price
$263.58
Total Value
$592.53K
Shares Held After
1,415,707
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
1,938
Price
$262.35
Total Value
$508.43K
Shares Held After
1,417,955
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
2,931
Price
$261.41
Total Value
$766.20K
Shares Held After
1,419,893
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
3,667
Price
$260.37
Total Value
$954.76K
Shares Held After
1,422,824
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
668
Price
$259.61
Total Value
$173.42K
Shares Held After
1,426,491
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
589
Price
$258.54
Total Value
$152.28K
Shares Held After
1,427,159
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma โ Director
Shares
407
Price
$257.32
Total Value
$104.73K
Shares Held After
1,427,748
% of Holdings
0.0%
Kinetik Holdings Inc. (KNTK)
Ellis Lindsay โ General Counsel, Chief Compliance Officer, and Corporate Secretary
Shares
1,260
Price
$46.92
Total Value
$59.12K
Shares Held After
46,905
% of Holdings
2.6%
MAXLINEAR, INC (MXL)
LITCHFIELD STEVEN G โ Chief Financial Officer and Chief Corporate Strategy Officer
Shares
20,000
Price
$17.50
Total Value
$349.92K
Shares Held After
368,364
% of Holdings
5.1%
Kinetik Holdings Inc. (KNTK)
Howard Trevor โ SVP, Chief Financial Officer
Shares
1,619
Price
$46.92
Total Value
$75.96K
Shares Held After
249,795
% of Holdings
0.6%
Kinetik Holdings Inc. (KNTK)
Stellato Steven โ EVP, Chief Accounting Officer and Administrative Officer
Shares
2,907
Price
$46.92
Total Value
$136.40K
Shares Held After
393,382
% of Holdings
0.7%
GEO GROUP INC (GEO)
KERNAN SCOTT MICHAEL โ Director
Shares
6,633
Price
$15.24
Total Value
$101.09K
Shares Held After
27,062
% of Holdings
19.7%
UNIVERSAL TECHNICAL INSTITUTE INC (UTI)
Hitchcock Todd A โ EVP/COO
Shares
16,500
Price
$37.33
Total Value
$615.95K
Shares Held After
104,084
% of Holdings
13.7%
HENRY SCHEIN INC (HSIC)
MLOTEK MARK E โ EVP, Chief Strategic Officer
Shares
1,825
Price
$80.81
Total Value
$147.48K
Shares Held After
80,554
% of Holdings
2.2%
HENRY SCHEIN INC (HSIC)
MLOTEK MARK E โ EVP, Chief Strategic Officer
Shares
4,100
Price
$80.80
Total Value
$331.26K
Shares Held After
82,379
% of Holdings
4.7%
CENTURY ALUMINUM CO (CENX)
Hoffman Robert F โ SVP, IT and CAO
Shares
10,000
Price
$56.33
Total Value
$563.30K
Shares Held After
67,172
% of Holdings
13.0%
FOSTER L B CO (FSTR)
English Aron R. โ 10% Owner
Shares
5,124
Price
$31.99
Total Value
$163.91K
Shares Held After
1,185,922
% of Holdings
0.4%
CRA INTERNATIONAL, INC. (CRAI)
Avery Thomas Aiken โ Director
Shares
1,026
Price
$187.35
Total Value
$192.22K
Shares Held After
14,339
% of Holdings
6.7%
BANK OF AMERICA CORP /DE/ (BAC)
DeMare James P โ Co-President
Shares
83,832
Price
$50.00
Total Value
$4.19M
Shares Held After
307,240
% of Holdings
21.4%
uniQure N.V. (QURE)
Kapusta Matthew C โ Director
Shares
14,581
Price
$9.06
Total Value
$132.10K
Shares Held After
660,658
% of Holdings
2.2%
AbbVie Inc. (ABBV)
Purdue David Ryan โ SVP, Controller
Shares
5,230
Price
$233.56
Total Value
$1.22M
Shares Held After
2,654
% of Holdings
66.3%
LandBridge Company LLC (LB)
WATSON CHARLES L. โ Director
Shares
9,670
Price
$75.19
Total Value
$727.07K
Shares Held After
77,250
% of Holdings
11.1%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES โ Chief Financial Officer
Shares
7,988
Price
$12.25
Total Value
$97.89K
Shares Held After
137,987
% of Holdings
5.5%
FIRST ADVANTAGE CORP (FA)
Jardine Bret T โ Chief Legal Officer
Shares
1,090
Price
$12.32
Total Value
$13.43K
Shares Held After
7,008
% of Holdings
13.5%
Acushnet Holdings Corp. (GOLF)
Hewett Gregory A. โ Director
Shares
4,206
Price
$100.00
Total Value
$420.60K
Shares Held After
37,017
% of Holdings
10.2%
Showing 4901โ4950 of 8783 transactions (page 99 of 176)